LataMed AI Corp. (OTC: LMED), a development-stage digital health and artificial intelligence technology company, announced that its Venezuelan operating affiliate, LataMed AI VE, will be featured in an interview in ES Salud Magazine, a healthcare-focused publication covering medical innovation and healthcare businesses. The feature is expected to be published in the July 2026 edition and will include an editorial profile and interview discussing the Company's healthcare technology initiatives and digital healthcare ecosystem strategy.
The Company noted that it has received a formal invitation from the publisher to participate in a broader editorial feature package expected to include coverage through both ES Salud Magazine and Eva’s Magazine. According to the invitation, the feature is anticipated to be distributed through multiple print, digital, social media, and online publication channels, significantly expanding the reach of the Company's message.
This publication provides an opportunity for LataMed AI to discuss its evolving healthcare platform and increase visibility among healthcare professionals, industry participants, and other stakeholders. The feature is expected to cover the Company's telehealth infrastructure, healthcare coordination technologies, payment accessibility initiatives, insurance integration opportunities, pharmacy-related services, and artificial intelligence-driven healthcare solutions currently under development.
Management believes that healthcare-focused industry publications are valuable for increasing awareness of healthcare innovation initiatives and engaging with stakeholders interested in the future of healthcare delivery. Dr. Kevin Rodan Levy, Chief Executive Officer, stated: "We appreciate the opportunity to share our vision for technology-enabled healthcare solutions and discuss the initiatives we are currently advancing throughout Latin America. We believe healthcare accessibility, coordination, and patient engagement remain important challenges, and we welcome opportunities to participate in industry discussions regarding the role of technology in addressing those challenges."
The feature is expected to highlight LataMed AI's broader vision of developing an integrated healthcare ecosystem designed to improve accessibility, coordination, and engagement for patients, healthcare providers, and other stakeholders across emerging markets. The Company aims to use this exposure to further increase awareness of its developing healthcare technology initiatives.
LataMed AI Corp. focuses on building telehealth infrastructure, healthcare coordination tools, analytics capabilities, and AI-enabled healthcare solutions for emerging markets, with an initial regional focus on Latin America. The Company expects the feature to be published during July 2026 and intends to provide additional updates once publication details are finalized, including information regarding publication dates, online availability, and print distribution.
For additional information, visit https://latamed.ai or review the Company’s filings with the U.S. Securities and Exchange Commission at www.sec.gov.
